Blue Biofuels Inc
Blue Biofuels Inc is a renewable energy company focused on the production and distribution of renewable fuels, primarily generating revenue through the sale of biofuels and related energy products.
Business. Blue Biofuels Inc (BIOF.PK) is a renewable energy company that operates within the broader energy sector. The firm is listed on the OTC market under the ticker BIOF.PK. Specific details regarding the company's operating segments, headquarters location, and geographic presence are not available in the provided data. Consequently, the business is described at the industry level as a participant in the renewable energy market.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Blue Biofuels Inc (BIOF.PK) is a renewable energy company that operates within the broader energy sector. The firm is listed on the OTC market under the ticker BIOF.PK. Specific details regarding the company's operating segments, headquarters location, and geographic presence are not available in the provided data. Consequently, the business is described at the industry level as a participant in the renewable energy market.
Blue Biofuels Inc has a highly leveraged capital structure, with total liabilities of $6.06 million and total equity of -$4.75 million, resulting in a negative debt-to-equity ratio of -0.92. The company's liquidity position is weak, as evidenced by a current ratio of 0.22, indicating that current assets are insufficient to cover current liabilities. The company holds $407,810 in cash and equivalents, but this is far below the $6.06 million in total liabilities, and the negative free cash flow of -$518,160 further exacerbates liquidity concerns.
Profitability metrics are deeply negative, with a net loss of $548,820 and an operating loss of $541,140. The return on assets (ROA) is -4.20%, and the return on equity (ROE) is 11.55%, which is misleading due to the negative equity base. These figures are well below the industry median for renewable fuels, where positive ROA and ROE are typically expected for operational viability.
The company's revenue is reported as $0, suggesting either a recent start-up or a period of operational suspension. There is no disclosed segment or geographic breakdown of revenue, and the company does not appear to have a diversified revenue stream. The lack of revenue concentration data implies a high degree of uncertainty regarding the company's market position and customer base.
Looking ahead, the company is expected to continue experiencing negative growth, with no revenue reported in the current fiscal year and no indication of a turnaround in the next fiscal year. The capital expenditure of -$19,830 suggests minimal investment in growth, and the negative operating and free cash flows indicate a lack of financial flexibility to fund operations or expansion.
The risk assessment highlights significant liquidity risk, with a medium rating due to the company's inability to meet short-term obligations. The dilution risk is rated as low, but the negative equity position and high leverage increase the potential for future dilution if the company requires additional capital. The key flag of negative net cash after subtracting total debt underscores the company's precarious financial position.
There are no recent filings or transcripts available to provide insight into the company's strategic direction or operational updates. The absence of disclosed events or management commentary makes it difficult to assess the company's near-term prospects or any mitigating factors that may be in place.
- Blue Biofuels Inc is operating at a significant loss with no reported revenue, indicating a lack of commercial viability.
- The company's capital structure is highly leveraged, with total liabilities exceeding total assets by a large margin.
- Liquidity is severely constrained, with a current ratio of 0.22 and negative free cash flow.
- The company's financial position is further weakened by a negative return on assets and a misleadingly high return on equity due to negative equity.
- There is no indication of revenue diversification or geographic exposure, and the company's growth trajectory is negative.
- The risk assessment highlights significant liquidity and capital structure risks, with no recent events to provide clarity on the company's strategic direction.
Bull / Bear case
Generated · model-assistedCash conversion ratio of 0.99 exceeds the cohort median of 0.97, suggesting slightly better cash generation from earnings.
Dilution risk is assessed as low, implying limited immediate threat to shareholder equity value from share issuance.
The company generated zero revenue across all five reported fiscal periods, indicating a complete lack of commercial sales activity.
Credit risk is flagged as high, reflecting significant concerns regarding the company's ability to meet debt obligations.
In focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Return On Assetsnet_income / total_assets
- Blue Biofuels Inc Market data — financials · 2026-05-27
Ownership & reference
Leadership
- Benjamin SlagerChairman of the Board, Chief Executive Officer
Insider activity
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Capex (YoY) (2025-12-31 vs 2024-12-31): -3.1%Derived (calculated)
- Return on equity (FY 2025-12-31): 77.6%Derived (calculated)
- Return on assets (FY 2025-12-31): -204.3%Derived (calculated)
- Current ratio (FY 2025-12-31): 0.03xDerived (calculated)
- Debt-to-equity (FY 2025-12-31): -1.38xDerived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 33.6%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -80.0%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -102.6%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 15.8%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 8.4%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): -1.0%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -30.2%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 1.3%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 20.7%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -80.0%Derived (calculated)
- Current assets (annual): USD 76.75KSEC XBRL filing
- Operating income (annual): USD -3.72MSEC XBRL filing
- Capex (annual): USD 68.9KSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES -0SEC XBRL filing
- Total operating expenses (annual): USD 3.72MSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES -0SEC XBRL filing
- Cash & equivalents (annual): USD 65.2KSEC XBRL filing
- Total liabilities (annual): USD 5.11MSEC XBRL filing
- R&D expense (annual): USD 2.31MSEC XBRL filing